Also known as N-ALLYL-MDA, 3,4-METHYLENEDIOXY-N-ALLYLAMPHETAMINE
MDAL is inactive, and unlike the closely related MDPR, which dramatically boosts the effects of LSD, it fails to enhance LSD and if anything seems to slightly counteract it. The author marvels that a difference of just two hydrogen atoms produces such opposite behavior.
Oral
Route dataPiHKAL
| Threshold | Light | Common | Strong | Heavy |
|---|---|---|---|---|
| — | — | 180–180 mg | — | —+ |
0180 mg
LightCommonStrongHeavy
Fact-sheets from PsychonautWiki. Harm-reduction reference only — not medical advice.